In Part 2 of our Future of Cancer Vaccines series, host Sia Anagnostou and experts Dr. Ken Carter, Deborah Barbara, and Dr. Mark R. Schleiss dive into the real-world opportunities and limitations of personalized neoantigen cancer vaccines. They discuss why these tailor-made therapies inspire so much excitement – and what challenges we must overcome (from AI hype to regulatory hurdles) to make them a reality. The Promise Meets the Reality In our panel discussion (Part 2 of a 3-part series on...

Future of Cancer Vaccines –  Over the past several years, we’ve all watched vaccine conversations become increasingly polarized. Discussions that should be grounded in science and public health have instead become emotionally charged and political. At the same time, national attention turned toward cancer vaccines again this year, especially after Larry Ellison’s appearance at the White House, where he spoke about AI-enabled personalized cancer vaccines that could be designed within 48 hours....

Each year on World Vaccine Day , we pause to recognize one of the most powerful tools in modern medicine: vaccines. These small vials...